68 research outputs found
Towards Robust and Reproducible Active Learning Using Neural Networks
Active learning (AL) is a promising ML paradigm that has the potential to
parse through large unlabeled data and help reduce annotation cost in domains
where labeling entire data can be prohibitive. Recently proposed neural network
based AL methods use different heuristics to accomplish this goal. In this
study, we show that recent AL methods offer a gain over random baseline under a
brittle combination of experimental conditions. We demonstrate that such
marginal gains vanish when experimental factors are changed, leading to
reproducibility issues and suggesting that AL methods lack robustness. We also
observe that with a properly tuned model, which employs recently proposed
regularization techniques, the performance significantly improves for all AL
methods including the random sampling baseline, and performance differences
among the AL methods become negligible. Based on these observations, we suggest
a set of experiments that are critical to assess the true effectiveness of an
AL method. To facilitate these experiments we also present an open source
toolkit. We believe our findings and recommendations will help advance
reproducible research in robust AL using neural networks
Comparison of percutaneous nephrostomy and double j stent in early normalization of renal function tests in patients with obstructive uropathy due to urolithiasis
Objective: To compare the mean normalization period of serum levels of urea and creatinine after placement of PCN tube or a DJ stent as emergency management for obstructive uropathy due to urolithiasis.
Methodology: A randomized controlled trial study is conducted in the Institute of Kidney Diseases, Hayatabad Medical Complex Peshawar from March 2018 - March 2019. The total sample of 416 was divided into two groups by the lottery method. Group A comprising of 208 patients who underwent Percutaneous Nephrostomy (PCN) and Group B Comprising of 208 in who underwent Double J Stenting for the relief of the obstructive uropathy respectively. Serum levels of urea and creatinine were recorded at 24, 96 and 144 hours post-operatively.
Results: The mean age of Group A 35.6 ± 8.4 years and the Mean age in Group B was 38.2± 10.4 years. The majority (76.6%) participants were male, including 70% were from PCN group and 79% were from DJ group. The time taken for normalization of serum urea level was 97.654 hours (4.068 days) and 106.453 hours (4.435 days) in the PCN and DJ stenting groups respectively. The normalization time of serum creatinine level was 95.4375 hours (3.98 days) and 104.8125 hours (4.36 days) in the patients undergoing PCN and DJ stenting respectively. The differences of normalization time in both groups were not statistically significant with p-values of 0.064 and 0.061 for normalization of serum urea and creatinine levels respectively.
Conclusion: Both the PCN and DJ stenting methods were equally effective in stone management in obstructive uropathy patients for normalization of elevated serum urea and creatinine levels
Modeling of Solar-Powered Desalination
The scarcity, global, and local demand of pure water for SDGs become prominent issue. The global emissions of CO2 and GHGs have put pressure to develop the solar-powered desalination plants. This article discussed the selection of site for the solar thermal desalination in Pakistan keeping the eye on sustainability and modeling and cost analysis of single solar stills technology at Lyari River in Karachi, Pakistan. Pakistan is among the water-deficit countries having 35% of population having lack of pure drinkable water. The plenty of solar irradiance and saline water in Pakistan make it very favorable for solar-powered desalination. The solar stills technology is one of the best technologies to meet the local demand of pure water. The modeling is composed of governing equations based on the law of conservation of mass and law of conservation of energy. The solar irradiance at Lyari River is taken from MERRA–2. The result depicted that the hourly production of distill water is 1 kg/m3 and 8 kg/m3 with and without the FRL lens. The cost of distill water produced from the solar stills having FRL lens is 33% less as compared with solar stills without FRL lens
Survivable Cloud Network Mapping for Disaster Recovery Support
Network virtualization is a key provision for improving the scalability and reliability of cloud computing services. In recent years, various mapping schemes have been developed to reserve VN resources over substrate networks. However, many cloud providers are very concerned about improving service reliability under catastrophic disaster conditions yielding multiple system failures. To address this challenge, this work presents a novel failure region-disjoint VN mapping scheme to improve VN mapping survivability. The problem is first formulated as a mixed integer linear programming problem and then two heuristic solutions are proposed to compute a pair of failure region-disjoint VN mappings. The solution also takes into account mapping costs and load balancing concerns to help improve resource efficiencies. The schemes are then analyzed in detail for a variety of networks and their overall performances compared to some existing survivable VN mapping scheme
Pharmacological Evaluation of Secondary Metabolites and Their Simultaneous Determination in the Arabian Medicinal Plant Plicosepalus curviflorus Using HPTLC Validated Method
© The Author(s) 2019. The present study aimed to identify biologically active secondary metabolites from the rare plant species, Pulsatilla patens subsp. patens and the cultivated P. vulgaris subsp. vulgaris. Chromatographic fractionation of the ethanolic extract of the roots of P. patens subsp. patens resulted in the isolation of two oleanane-type glycosides identified as hederagenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin 3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (3.3 mg, patensin). HPLC analysis of the methanolic extract of the crude root of P. patens subsp. patens and P. vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin D (hederagenin 3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside). Chromatographic analysis using GC-MS of the silylated methanolic extracts from the leaves and roots of these species identified the presence of carboxylic acids, such as benzoic, caffeic, malic, and succinic acids. The extracts from Pulsatilla species were tested for their antifungal, antimicrobial, and antimalarial activities, and cytotoxicity to mammalian cell lines. Both P. patens subsp. patens and P. vulgaris subsp. vulgaris were active against the fungus Candida glabrata with the half-maximal inhibitory concentration (IC 50 ) values of 9.37 µg/mL and 11 µg/mL, respectively. The IC 50 values for cytotoxicity evaluation were in the range of 32–38 μg/mL for P. patens subsp. patens and 35–57 μg/mL for P. vulgaris subsp. vulgaris for each cell line, indicating general cytotoxic activity throughout the panel of evaluated cancer and noncancer cells
Numerical study of hydrodynamic flow of a Casson nanomaterial past an inclined sheet under porous medium
The main aim of the current paper is to investigate the mass and heat transportation of a Casson nanomaterial generated by the inclination of the surface. The magnetic field effect along with suction or injection are considered. The working nanomaterial is taken into consideration based on the concept of the Buongiorno nanofluid theory, which explores the thermal efficiencies of liquid flows under movement of Brownian and thermophoretic phenomena. The emergent system of differential expressions is converted to dimensionless form with the help of the appropriate transformations. This system is numerically executed by the implementation of Keller–Box and Newton's schemes. A good agreement of results can be found with the previous data in a limiting approach. The behavior of the physical quantities under concern, including energy exchange, Sherwood number, and wall shear stress are portrayed through graphs and in tabular form. The Nusselt number and Sherwood number are found to diminish against the altered magnitudes of Brownian motion and the inclination parameter. Moreover, the velocity profile decreases with the growth of the inclination effect. In the same vein, the buoyancy force and solutal buoyancy effects show a direct relation with the velocity field. The outcomes have promising technological uses in liquid-based systems related to stretchable constituents
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019 : a systematic analysis for the Global Burden of Disease Study 2020, Release 1
Background Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. Robust estimates of routine vaccine coverage are needed to identify past successes and persistent vulnerabilities. Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time. Methods For this analysis we collated 55 326 country-specific, cohort-specific, year-specific, vaccine-specific, and dosespecific observations of routine childhood vaccination coverage between 1980 and 2019. Using spatiotemporal Gaussian process regression, we produced location-specific and year-specific estimates of 11 routine childhood vaccine coverage indicators for 204 countries and territories from 1980 to 2019, adjusting for biases in countryreported data and reflecting reported stockouts and supply disruptions. We analysed global and regional trends in coverage and numbers of zero-dose children (defined as those who never received a diphtheria-tetanus-pertussis [DTP] vaccine dose), progress towards GVAP targets, and the relationship between vaccine coverage and sociodemographic development. Findings By 2019, global coverage of third-dose DTP (DTP3; 81.6% [95% uncertainty interval 80.4-82 .7]) more than doubled from levels estimated in 1980 (39.9% [37.5-42.1]), as did global coverage of the first-dose measles-containing vaccine (MCV1; from 38.5% [35.4-41.3] in 1980 to 83.6% [82.3-84.8] in 2019). Third- dose polio vaccine (Pol3) coverage also increased, from 42.6% (41.4-44.1) in 1980 to 79.8% (78.4-81.1) in 2019, and global coverage of newer vaccines increased rapidly between 2000 and 2019. The global number of zero-dose children fell by nearly 75% between 1980 and 2019, from 56.8 million (52.6-60. 9) to 14.5 million (13.4-15.9). However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019. Interpretation After achieving large gains in childhood vaccine coverage worldwide, in much of the world this progress was stalled or reversed from 2010 to 2019. These findings underscore the importance of revisiting routine immunisation strategies and programmatic approaches, recentring service delivery around equity and underserved populations. Strengthening vaccine data and monitoring systems is crucial to these pursuits, now and through to 2030, to ensure that all children have access to, and can benefit from, lifesaving vaccines. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe
The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019
Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates of overweight and wasting prevalence among children under 5 years of age in 105 low- and middle-income countries (LMICs) from 2000 to 2017 and aggregate these to policy-relevant administrative units. Wasting decreased overall across LMICs between 2000 and 2017, from 8.4% (62.3 (55.1–70.8) million) to 6.4% (58.3 (47.6–70.7) million), but is predicted to remain above the World Health Organization’s Global Nutrition Target of <5% in over half of LMICs by 2025. Prevalence of overweight increased from 5.2% (30 (22.8–38.5) million) in 2000 to 6.0% (55.5 (44.8–67.9) million) children aged under 5 years in 2017. Areas most affected by double burden of malnutrition were located in Indonesia, Thailand, southeastern China, Botswana, Cameroon and central Nigeria. Our estimates provide a new perspective to researchers, policy makers and public health agencies in their efforts to address this global childhood syndemic
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens
- …